Max Healthcare Institute Ltd banner

Max Healthcare Institute Ltd
BSE:543220

Watchlist Manager
Max Healthcare Institute Ltd Logo
Max Healthcare Institute Ltd
BSE:543220
Watchlist
Price: 1 096.05 INR 0.46%
Market Cap: ₹1.1T

Wall St Price Targets

MAXHEALTH Price Targets Summary
Max Healthcare Institute Ltd

Wall Street analysts forecast MAXHEALTH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MAXHEALTH is 1 180.08 INR with a low forecast of 833.08 INR and a high forecast of 1 448.7 INR.

Lowest Forecast
Price Target
833.08 INR
24% Downside
Average Forecast
Price Target
1 180.08 INR
8% Upside
Highest Forecast
Price Target
1 448.7 INR
32% Upside
Max Healthcare Institute Ltd Competitors:
Price Targets
RET
Retail Estates NV
2% Upside
FCL
FINEOS Corporation Holdings PLC
67% Upside

Revenue
Forecast

46% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-23%
Average Miss
46% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-23%
Average Miss

Over the last 5 years, the compound annual growth rate for Revenue has been 46%. The projected CAGR for the next 4 years is 24%.

Gross Profit
Forecast

45% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
-14%
Average Miss
45% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
-14%
Average Miss

Over the last 5 years, the compound annual growth rate for Gross Profit has been 45%. The projected CAGR for the next 4 years is 23%.

Operating Income
Forecast

100% / Year
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
-21%
Average Miss
100% / Year
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
-21%
Average Miss

Over the last 5 years, the compound annual growth rate for Operating Income has been 100%. The projected CAGR for the next 4 years is 26%.

Pre-Tax Income
Forecast

156% / Year
Past Growth
33% / Year
Estimated Growth
Estimates Accuracy
-20%
Average Miss
156% / Year
Past Growth
33% / Year
Estimated Growth
Estimates Accuracy
-20%
Average Miss

Over the last 5 years, the compound annual growth rate for Pre-Tax Income has been 156%. The projected CAGR for the next 3 years is 33%.

Net Income
Forecast

79% / Year
Past Growth
28% / Year
Estimated Growth
Estimates Accuracy
-22%
Average Miss
79% / Year
Past Growth
28% / Year
Estimated Growth
Estimates Accuracy
-22%
Average Miss

Over the last 5 years, the compound annual growth rate for Net Income has been 79%. The projected CAGR for the next 4 years is 28%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is MAXHEALTH's stock price target?
Price Target
1 180.08 INR

According to Wall Street analysts, the average 1-year price target for MAXHEALTH is 1 180.08 INR with a low forecast of 833.08 INR and a high forecast of 1 448.7 INR.

What is the Revenue forecast for Max Healthcare Institute Ltd?
Projected CAGR
24%

Over the last 5 years, the compound annual growth rate for Revenue has been 46%. The projected CAGR for the next 4 years is 24%.

What is the Gross Profit forecast for Max Healthcare Institute Ltd?
Projected CAGR
23%

Over the last 5 years, the compound annual growth rate for Gross Profit has been 45%. The projected CAGR for the next 4 years is 23%.

What is the Operating Income forecast for Max Healthcare Institute Ltd?
Projected CAGR
26%

Over the last 5 years, the compound annual growth rate for Operating Income has been 100%. The projected CAGR for the next 4 years is 26%.

What is the Pre-Tax Income forecast for Max Healthcare Institute Ltd?
Projected CAGR
33%

Over the last 5 years, the compound annual growth rate for Pre-Tax Income has been 156%. The projected CAGR for the next 3 years is 33%.

What is the Net Income forecast for Max Healthcare Institute Ltd?
Projected CAGR
28%

Over the last 5 years, the compound annual growth rate for Net Income has been 79%. The projected CAGR for the next 4 years is 28%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett